Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) combined with MRI are under clinical evaluation to enhance detection of neurodegenerative diseases. A major improvement would be to link therapeutic drugs to the SPIONs to achieve targeted drug delivery, either at the cell surface or intracellularly, together with active disease detection, without inducing cell reaction. Our objectives were to define the characteristics of SPIONS able to achieve cellspecific interaction with brain-derived structures. Our system consisted in an ironoxide core 
Introduction
Nanotechnologies and nanostructures are becoming an option in human medical application, including imaging or the delivery of therapeutic drugs to cells, tissues and organs. Most of these latter applications would require that drug-loaded nanoparticles enter organ and tissues, and are taken up by cells. Several studies have shown that the tissue, cell and even cell organelles distribution (Alexiou et al., 2000; Savic et al., 2003) of drugs may be controlled and improved by their entrapment in colloidal nanomaterials, mainly of the micellar structure, such as nanocontainers. The development of a large variety of colloidal dispersions of Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) has added a supplementary function to nanomaterials, their magnetic properties, which can lead to a range of new biological, biomedical and diagnostic applications. In particular, the application of the different forms of iron oxides for radiological diagnostic procedures, to document vascular leakage, macrophage imaging or cell tracking (Weissleder et al., 1997; Ruehm et al., 2001; Brigger et al., 2002; Hoehm et al., 2002; Kircher et al., 2003; Corot et al., 2004; Neuwelt et al., 2004; Raynal et al., 2004; Sundstrom et al., 2004; Triverdi et al., 2004; Dalrup et al., 2005) is gaining wide acceptance in radiological practice, but these agents are only very poorly taken up by cells, depending on their size or the expression of the scavenger receptors by cells (Ruehm et al., 2001; Corot et al., 2004; Raynal et al., 2004; Triverdi et al., 2004) .
Therefore the next challenge will be to develop and define the chemical and biophysical characteristics of biocompatible SPIONs which are able to intracellularly deliver therapeutic drugs, in particular in neurodegenerative diseases without inducing deleterious cell reaction, coupled to the detection of active lesions. SPIONs are able, under some conditions, to pass the blood-brain barrier, either by direct transport (Lockman et al., 2003; 2004; Kreuter, 2004; Muller and Keck, 2004) , or using an indirect route via the olfactory bulb (Obersdörster et al, 2004; Kandimalla and Donovan, 2005) and to document active lesions by MRI in This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on jpet.aspetjournals.org Downloaded from JPET#101915 5 neurodegenerative disorders . However, particles that can penetrate into the brain, and other organs, also pose a potential health risk (Obersdörster, 2004; Colvin, 2003; Borm and Kreyling, 2004; Hoet et al., 2004) . A better understanding of how properties of nanoparticles define their interactions with cells, tissues and organs in humans and animals is a considerable scientific challenge but one that must be addressed to ascertain the feasibility of using nanobiotechnologies in biomedical applications..
In a preliminary approach, we have prepared and characterized various polyvinyl-alcoholcoated SPIONs (Chastellain et al., 2004; Petri-Fink et al., 2005) which displayed the potential to interact with non-phagocytic human tumor cells. In order to evaluate their brain biocompatibility and their potential for drug delivery to the brain, we determined the uptake of and inflammatory reaction towards SPIONs of various size and coating characteristics, 
Methods

SPIONs
Iron oxide nanoparticles (ferrofluid) were prepared according to described methods (Massart et al., 1995; van Ewijk et al., 1999; Chastellain et al., 2004) . Briefly, SPIONs were prepared by alkaline co-precipitation of ferric (0.086 M) and ferrous (0.043 M) chlorides (Fluka, Buchs, Switzerland) . After washing with water, the black precipitate was refluxed in 0.8 M nitric oxide-0.21 M Fe(NO 3 ) 3 .9H 2 O (Fluka) for 1 h, cooled and the brown precipitate was dispersed in H 2 O, then dialyzed for 2 days against 0.01 M nitric acid. The dialyzed iron oxide nanoparticles were mixed with the various polyvinyl alcohol (PVA) polymers as previously described (Chastellain et al., 2004; Petri-Fink et al., 2005) and the pH was adjusted to 7 to obtain PVA-coated nanoparticles, either native-, amino-, carboxylate-and thiol-PVASPIONs. For the experiments described here the ratio of polymer/iron was 10 (45 mg polymer/ml and 4.5 mg iron/ml, final concentrations), and the ratio of PVA/functionalizedPVA copolymer was 45 (mass ratio). Dextran-coated Endorem (Endorem®, Guerbet, G 534-14, lot 134, 11.2 mg Fe/ml) and Sinerem (Ferrumoxtran-10, AMI227, Guerbet, G534-25, lot ADS03, 20 mg Fe/ml) were provided by Guerbet, France.
The various nanoparticles used in this study and their biochemical characteristics are summarized in Table 1 and Figure 1. Cy3.5-SPIONs or Cy5.5-SPIONs were prepared by reacting under shaking 500 µl amino-PVA-SPIONs (2-5x10 15 nanoparticles/ml, 4.5 mg iron/ml) with 500 µl Cy3.5-N-hydroxy-succinimide ester or Cy5.5-N-hydroxy-succinimide ester (30 mmole NH 2 -labelling capacity, Cy3.5-or Cy5.5-monoreactive dye, Amersham
Biosciences, Upsala, Sweden) in 25 mM sodium carbonate buffer pH 9.5 for 2 h in the dark at room temperature, followed by sequential gel filtration through pre-packed Sephadex G-25 columns (8.3 ml bed volume) (Amersham Biosciences) first in 25 mM sodium phosphate buffer pH 7.5, then in nanopure water.
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The characteristics and culture conditions of the rat brain-derived endothelial EC219 (Juillerat-Jeanneret et al., 1992; 2003) and the murine N9 et N11 microglial (Murata et al., 1994; 1997) (kindly provided by P Ricciardi-Castagoli, Milan, Italy) cell lines have been described. EC219, N9 and N11 cells were previously shown to produce nitric oxide under inflammatory stress (Murata et al., 1994; 1997) . Cells were routinely maintained in their culture medium containing FCS and antibiotics (both from Gibco, Invitrogen, Basel, Switzerland). Three days prior to experiments, the cells were detached in trypsin-EDTA (Gibco) and grown in complete medium in 96-or 48-well plates (Costar, Corning, NY, USA).
On the day of experiment, medium was changed to fresh complete medium, and the various nanoparticles preparations (cf above) were added for the concentration, time and temperature indicated, together with 1 µg/ml lippopolysaccharide (LPS, Sigma, Buchs, Switzerland) when indicated. At the end of the experiment, either the MTT (3-(4,5-dimethylthiazolyl)-2,5-diphenyl-2H-tetrazolium bromide, Sigma) test was performed for the two last hours to determine cell viability (cf below) or the cell layers were washed twice in saline, or when indicated for 5 min at room temperature in 0.15 M Na-acetate buffer pH 5.2 to remove cell surface nanoparticles, and cellular iron content was quantified (cf below). Alternatively, histological staining of iron or confocal microscopy was performed (cf below).
Aggregate cultures and treatments
Brain-cell derived aggregates were prepared from the telencephalon of E16 rat embryos (OFA/SPF, BRL, Füllinsdorf, Switzerland) and maintained in defined medium under continuous giratory agitation, essentially as previously described (Honegger and TschuddiMonnet, 2000 Juillerat-Jeanneret et al., 2003) .
Evaluation of cell viability, protein content and NO
The evaluation of MTT reduction to quantify metabolically active cells was performed essentially as previously described (Petri-Fink et al., 2005) . Cell layers were extracted in PBS-0.1% Triton X-100 and protein content was quantified with the BCA kit (BCA TM , Pierce, Socochim, Lausanne, Switzerland) and bovine serum albumin as standard. The production of NO was measured in culture supernatants as the stable NO-derivative NO 2 -with the Griess reagent, essentially as previously described (Murata et al., 1994) . 
Total cell iron determination
Histochemical determination of iron
Histological sections (5 µm) of frozen aggregates were cut or cells were grown on histological glass slides in medium containing 10% FCS and antibiotics. Then medium was changed to fresh complete medium containing 1µl aminoPVA-SPION (4.5 µg iron/ml culture medium)
for 5 to 240 min at 37°C, the medium was aspirated, the cell layer was washed 3 times, fixed for 15 min in 4% buffered paraformaldehyde at room temperature, washed, and air-dried. 
Lectin histochemistry
Histological sections (5 µm) of aggregates were post-fixed for 15 min in 4% buffered paraformaldehyde and incubated overnight at 4°C in a solution of horseradish peroxidaseconjugated Bandeirea simplicifolia-1 lectin (Sigma, 12.5 µg/ml in 0.1 M Tris-NaCl -1%
Triton X-100 pH 7.4 ), then exposed to 0.002 % diaminobenzamidine (Fluka) and counterstained with hematoxylin (Honegger and Tschuddi-Monnet, 2000; Juillerat-Jeanneret et al., 2003) . 
Confocal microscopy
N9
Calculations of results
This article has not been copyedited and formatted. The final version may differ from this version. Each experiment was repeated in triplicate wells at least two times. Means and standard deviation were calculated.
For confocal microscopy, data were analyzed using SYSTAT 10 (SPSS, Chicago, IL, USA).
Statistical significance was determined by analysis of variance (ANOVA) followed by posthoc Tukey's test. Differences were considered significant where p<0.05.
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Results
First we determined the uptake ( In order to further determine the effects of the SPION particle size and of inflammatory cell activation for efficient cell uptake, we evaluated whether dextran-coated SPIONs with a larger hydrodynamic size (beads) (Endorem, hydrodynamic diameter 80-150 nm) would display an increased uptake by EC219 and N11 cells, either resting or LPS-activated cells (Table 4) . In EC219 endothelial cells, Endorem uptake was low, and did not increase with time of exposure or the presence of LPS (Table 4) , however, endothelial cells did respond to LPS by increasing NO release (results not shown). We have previously shown that EC219, N9 and N11 cells respond to inflammatory stimuli, including LPS, by producing NO (Murata et al., 1994; 1997) . In N11 microglial cells, spontaneous uptake was slow, but increased with time (Table   4) , the amount of Endorem added to the cells (Figure 2) . LPS addition to N11 cells increased SPION uptake ( NativePVA-, carboxylatePVA-or thiolPVA-SPIONs were not taken up by N11 microglial cells, and only aminoPVA-SPIONs were taken up by N11 cells (Figure 3A) . EC219 cells also took up aminoPVA-SPIONs ( Figure 3B ). However, uptake saturation was reached at lower aminoPVA-SPION concentration in brain-derived EC219 endothelial cells than N11 microglial cells. To determine whether the uptake of aminoPVA-SPIONs induced inflammatory activation of cells, we measured NO in the culture supernatants of cells exposed for up to 24 h to aminoPVA-SPIONs. NO production was never detected (results not shown).
In order to evaluate whether all cells, or only some cells of a culture were able to take up the aminoPVA-SPIONs, we exposed N11 and EC219 cells grown on histological slides to aminoPVA-SPIONs for increasing time periods, and performed iron histological staining (Figure 4) . These experiments demonstrated a time-dependent cell-associated increase of iron in all cells, comparable to total iron determination in cell extracts (Figure 3 ) and the pattern of iron location suggested internalization by the cells.
In order to confirm internalization of amino-SPIONs by cells, we prepared aminoPVASPIONs of which one out of ten amino-group was covalently derivatized by the fluorescent reporter molecule Cy3.5 ( Figure 5A was effectively intracellular, we performed confocal microscopy. In N9 cells (nucleus = blue (DAPI), membrane = green (DAF), Cy.3.5 = red) exposed for short exposure (20 min) to Cy3.5-aminoPVA-SPIONs, no uptake was observed ( Figure 6A ), whereas after 20 h, intracellular location of the fluorophore was documented ( Figure 6B ). This time-course paralleled the uptake of iron by N9 cells as determined by iron histological staining ( Figure   6C ). From the aspect of cells under phase contrast and confocal microscopy, the absence of cytotoxicity was evident.
Therefore these experiments demonstrated that brain-derived endothelial and microglial cells internalize aminoPVA-SPIONs, and that uptake did not result in the production of NO as a marker of inflammatory activation of these cells. In order to determine whether these aminoPVA-SPIONs have the potential to be taken up by and massively invade brain parenchyma and whether they would induce brain activation, we used a 3-dimensional braincell aggregate culture model, at various stages of neural cell differentiation (Honegger and Tschuddi-Monnet, 2000) . In this model, dissociated embryonic neural cells are reassociated under gyratory culture conditions, and astrocytes, neuron, oligodendrocytes, and microglial cells differentiate with the time in culture (Honegger and Tschuddi-Monnet, 2000) . After 1 week (undifferentited aggregates) to 4 weeks (differentiated aggregates) in culture, aggregates were exposed to aminoPVA-SPIONs and histological iron determination and BS-1 lectin staining (an histological marker of microglial activation) as well as determination of NO in the aggregate culture medium were performed. Different patterns of iron staining were observed with the stages of differentiation, however at any stage only the tanicytes (the specific astrocytic cell external layer of brain ventricles) of aggregates demonstrated detectable iron uptake ( Figure 7A) , and no deep brain aggregate penetration was observed. At early differentiation stages (1-2 weeks), iron staining was more irregular and sometimes located in cells of the second layer of the aggregates, whereas at higher differentiation stages This article has not been copyedited and formatted. The final version may differ from this version. 
Discussion
Treatment options for a number of human disorders, in particular those of the brain, are often limited by the high drug concentrations required for efficacy, the presence of drug resistance mechanisms, and the poor cell selectivity of therapeutic agents. These characteristics are especially important in the context of neurodegenerative disorders. The brain is separated from the bloodstream by the blood-brain barrier (BBB) (Risau and Wolburg, 1990 ), a highly specialized vascular system consisting of endothelial cells, pericytes and astrocytes. The presence of tight junctions between cells of the BBB protects the brain from blood-borne pathogens and chemicals, but also impedes the access of therapeutic drugs. In certain disorders, however, such as neurodegeneration and brain cancer, the BBB becomes compromised which creates a window for drug delivery (Muldoon et al., 1999; Lockman et al., 2004) . Alternatively, therapeutics agents can be transported across an intact BBB by hijacking the endogenous transport systems of the cerebral vasculature (Lockman et al., 2003) . Another approach to drug delivery to the brain is to utilize the connection that exists between the nervous and olfactory systems (Borm and Kreyling, 2004) . Regardless of the route used to deliver drugs into the brain, the diffusion of the drug delivery devices into the brain parenchyma must be controllable and must avoid activation of microglial cells, since the brain possesses its own macrophage population, the microglia, which are involved in the development of neurodegenerative disorders (Perry et al., 1993) and could be activated by the treatments. Macrophages in inflammatory areas, from the brain or other tissues, are main targets for nanoparticles, whether magnetic or not (Ruehm et al., 2001; Corot et al., 2004; Raynal et al., 2004; Triverdi et al., 2004; Chellat et al., 2005) . In the present manuscript, our experimental approaches were designed to evaluate whether i) intracellular uptake by brain cells of functionalized SPIONs is possible and would be harmful and inflammation-inducing This article has not been copyedited and formatted. The final version may differ from this version. Therefore, our goals in the present study were to define the biophysical, biological and biochemical characteristics of SPIONs with such properties. Using the rat brain-derived EC219 endothelial cells, the murine N9 and N11 microglial cells, and differentiating aggregate brain cells in three-dimensional cultures, we have evaluated the cellular uptake, the cytotoxicity, and the interaction of these cells with various nanoparticles. Macrophages and endothelial cells express organ-specific properties, but macrophages and endothelial cells of rodent origin (Murata et al., 1994; 1997) , as well as rodent brain-cells in aggregate culture Importantly, no cellular reaction was observed following cellular uptake of aminoPVASPIONs, as estimated by nitric oxide production or the evaluation of microglial activation.
These nanoparticles were also well tolerated when injected into normal mice.
Previous experiments using magnetic approach to drug targeting have been performed by some groups with magnetic particles or magnetic liposomes ranging from 10 µm to 100 nm, loaded with chemotherapeutic agents (Alexiou et al., 2000; Rudge et al., 2001) . Some positive effects were obtained, in particular a decrease of general toxicity of the agents, due to generally lower doses required. Magnetically-controlled drug targeting and delivery requires magnetic nanoparticles with high magnetization properties and the possibility of surface derivatization for drug attachment in order to achieve magnetic drug delivery. SPIONs, or super paramagnetic nanoparticles with an ironoxide core diameter of less than 10 nm, exhibit outstanding magnetic properties, as they show no magnetization in the absence of a magnetic field but become strongly magnetized in the presence of one. Biocompatible superparamagnetic nanoparticles have been developed for in vivo biomedical applications mainly in magnetic resonance imaging (Weissleder et al., 1997) , and have only been evaluated pre-clinically in tissue-specific delivery of therapeutic agents (Lubbe et al., 1996) .
Two advantages of SPIONs are their low toxicity to humans and the possibility to exploit their superparamagnetic properties (Weissleder et al., 1997; Ruehm et al., 2001; Brigger et al., 2002; Hoehm et al., 2002; Kircher et al., 2003; Corot et al., 2004; Neuwelt et al., 2004; Raynal et al., 2004; Sundstrom et al., 2004; Triverdi et al., 2004; Dalrup et al., 2005) .
Although the use of SPIONs as magnetic resonance imaging contrast agents is established, their potential as drug targeting and drug delivery agents is still in early stage of evaluation.
In drug delivery application, the critical step is the transport across cell layers (Koch et al., 2005) scavenger receptor-mediated endocytosis (Raynal et al., 2004) . Macaque T cells labelled with monocrystalline SPIONs following adsorptive pinocytosis or receptor-mediated endocytosis and which localized in the cytoplasm did not cause any measurable effets on T cell function (Sundstrom et al., 2004) . Therefore, highly specific biological, biochemical and biophysical properties are required to develop drug-derivatized SPIONs that can detect lesions and that are capable of tissue-and cell-selective drug delivery. The detection systems must be noninvasive, and the agents allowing detection must be biocompatible and biodegradable. In addition, cell activation and the production of inflammatory molecules must be avoided.
Polymeric coating of SPIONs has been used to prevent nanoparticle aggregation in biological media to achieve non-invasive detection system in enhanced magnetic imaging. Once directed toward the target cells, the functionalized SPIONs can be immobilized at a particular site using external magnetic fields, thus providing an additional degree of control over the drug delivery. In addition, varying the biochemical characteristics of the coating polymer may allow for selective intracellular or extracellular delivery of the drugs to the target cells.
In and it is assumed that each vessel is separated from its neighbor by around 40 µm, which means that every neural cell almost has its private vessel and that once a drug has traversed the blood brain barrier its brain distribution is immediate. Therefore these nanostructures represent useful tools for further development of nanostructures able of intracellular delivery of therapeutic agents to brain cells. Murine N11 microglial cells were exposed to increasing concentrations of Endorem for 16 h.
Legends for
Then cell-bound iron was measured using the Prussian Blue reaction and means + SD were calculated. Experiments were repeated twice in triplicate wells. (B and C). Cells were grown in culture medium in culture wells, then exposed to Cy3.5-SPIONs (4-83 µg iron/ml, final concentration) for 2 h or 4 h, either at 4°C or 37°C. Then following extensive washing, Cy3.5 fluorescence was measured in the intact cell layer (B), followed by cellular iron content determined using Prussian Blue reaction (C) in cell extracts. A: Differentiating brain-cell aggregates after 1, 2, 3 or 4 weeks of culture and differentiation, were exposed for 3 days to aminoPVA-SPIONs, and culture was continued for 2 other days without aminoPVA-SPIONs. Iron was determined on histological slides by Prussian Blue reaction (blue staining, cell nuclei are red).
B: microglial cells activation was controlled by BS-1 lectin staining (dark brown staining).
